|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61P 11/14 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 3377064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16819325.8 |
| Date of filing the European patent application | 2016-12-27 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (86) | Number | PCT/EP2016/082698 |
| Date | 2016-12-27 |
| (87) | Number | WO 2017/118584 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201662276237 P | 2016-01-08 | US | |
| 201662408921 P | 2016-10-17 | US |
| (72) |
TROWER, Mike, GB
|
| (73) |
NeRRe Therapeutics Limited,
Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX,
GB
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Orvepitantas, skirtas lėtinio kosulio gydymui |
| ORVEPITANT FOR THE TREATMENT OF CHRONIC COUGH |
| Payment date | Validity (years) | Amount | |
| 2024-12-02 | 9 | 208.00 EUR |
| 2025-12-27 |